The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints

Documenti analoghi

• Phase II Trials for Heterogeneous Patient Populations with a Time-to-Event Endpoint
  di: Jung, Sin-Ho
  Pubblicazione: (2017)
• Mixed response and time-to-event endpoints for multistage single-arm phase II design
  di: Lai, Xin, et al.
  Pubblicazione: (2015)
• Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
  di: Hall, Peter, et al.
  Pubblicazione: (2015)
• A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
  di: Belin, Lisa, et al.
  Pubblicazione: (2017)
• The consensus studysquamous cell carcinoma of the oropharynx: late phase clinical trials; core outcomes
  di: Waters, Aoife, et al.
  Pubblicazione: (2013)